Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor
A Efeyan, V Fabris, S Merani, C Lanari… - Breast cancer research …, 2004 - Springer
We report the establishment of two mouse mammary cancer cell lines, MC7-2A and MC7-2B
obtained from a mouse mammary carcinoma induced by medroxyprogesterone acetate …
obtained from a mouse mammary carcinoma induced by medroxyprogesterone acetate …
Five Novel Hormone-responsive Cell Lines Derived from Murine Mammary Ductal Carcinomas: In Vivo and in Vitro Effects of Estrogens and Progestins
We have developed an experimental model of mammary carcinogenesis in which the
administration of medroxyprogesterone acetate (MPA) to female BALB/c mice induces …
administration of medroxyprogesterone acetate (MPA) to female BALB/c mice induces …
Hormone dependence of a mouse mammary tumor line inducedin vivo by medroxyprogesterone acetate
The administration of MPA to virgin female BALB/c mice led to the development of mammary
adenocarcinomas, which in further in vivo transplants gave rise to both MPA-dependent and …
adenocarcinomas, which in further in vivo transplants gave rise to both MPA-dependent and …
Establishment and characterization of three new breast‐cancer cell lines
B Siwek, D Larsimont, M Lacroix… - International journal of …, 1998 - Wiley Online Library
We have established and characterized 3 new breast‐cancer cell lines from pleural
effusions of patients with advanced breast cancer. All 3 cell lines, designated IBEP‐1, IBEP …
effusions of patients with advanced breast cancer. All 3 cell lines, designated IBEP‐1, IBEP …
Estrogen inhibition of MPA‐induced mouse mammary tumor transplants
Estrogen compounds were used to treat mice bearing syngeneic transplants of
medroxyprogesterone acetate (MPA)‐induced BALB/c mammary adenocarcinomas. Both …
medroxyprogesterone acetate (MPA)‐induced BALB/c mammary adenocarcinomas. Both …
A METASTATIC BREAST TUMOR CELL LINE, GI‐101A, IS ESTROGEN RECEPTOR POSITIVE AND RESPONSIVE TO ESTROGEN BUT RESISTANT TO …
JJ MORRISSEY, S RANEY - Cell biology international, 1998 - Wiley Online Library
The progression of human breast cancer is often associated with a loss of estrogen
dependence for growth, a resistance to estrogen antagonists such as tamoxifen, and the …
dependence for growth, a resistance to estrogen antagonists such as tamoxifen, and the …
Mammary adenocarcinomas induced by medroxyprogesterone acetate: Hormone dependence and egf receptors of BALB/c In vivo sublines
Mammary adenocarcinomas were induced by medroxyprogesterone acetate (MPA) in
female BALB/c mice. From 5 primary tumors, 9 different sublines were established by sc …
female BALB/c mice. From 5 primary tumors, 9 different sublines were established by sc …
Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment
LA Helguero, M Viegas, A Asaithamby… - Breast Cancer Research …, 2003 - Springer
Using medroxyprogesterone acetate (MPA) as a carcinogen, we were able to induce in
BALB/c female mice, several progestin-dependent mammary ductal carcinomas that regress …
BALB/c female mice, several progestin-dependent mammary ductal carcinomas that regress …
Reversal of estrogen‐resistance in murine mammary adenocarcinomas
MF Montecchia, A Molinolo, C Lanari - Breast cancer research and …, 1999 - Springer
From mouse mammary progestin‐dependent (PD) adenocarcinomas induced with
medroxyprogesterone acetate (MPA) we developed several in vivo lines that are maintained …
medroxyprogesterone acetate (MPA) we developed several in vivo lines that are maintained …
A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice
M Simian, T Manzur, V Rodriguez… - Breast cancer research …, 2009 - Springer
Currently, an in vivo spontaneous model of estrogen dependent, tamoxifen sensitive breast
cancer does not exist. We show here the characterization of the M05 mammary tumor that …
cancer does not exist. We show here the characterization of the M05 mammary tumor that …